Health Data Research UK Selects MMS as Data Services Partner for International COVID-19 Data Alliance

LONDON–(COMMERCIAL THREAD) – MMS Holdings Inc. (MMS) – an award-winning, data-driven CRO – today announced that it has been selected by Health Data Research UK (HDR UK) – the national institute for data science health – as a partner to support the International COVID-19 Data Alliance (ICODA) initiative. MMS was selected from a group of some of the world’s top clinical research organizations to provide data engineering services to support a globally coordinated, data-driven health research response to combat the COVID-19 pandemic.

ICODA is an open and inclusive global collaboration of leading organizations in life sciences, philanthropy and research who have come together to harness the power of health data to respond to the COVID-pandemic. 19. Uniting data from a wide range of contributors will enable discoveries that will help treat and prevent COVID-19 and coordinate effective data responses to the health challenges of the future.

“The International COVID-19 Data Alliance (ICODA), convened by Health Data Research UK, is delighted to partner with MMS for data engineering services in support of our existing pilots and future Grand pilots. Challenges, ”said Neil Postlethwaite, Technical Director, ICODA. “We look forward to the MMS team supporting our data contributors with their expertise to accelerate data contribution to the ICODA initiative. Their field-specific knowledge and experience will ensure our researchers have access to higher quality datasets and can focus on answering key research questions in the COVID-19 pandemic. ”

“The values ​​on which the MMS was built closely align with those of HDR UK and ICODA, and we are proud to help them make data accessible to health researchers and scientists around the world,” said Alan Nicolle, Director principal of operations EU & SA, MMS. “At MMS, we take a people-centered approach to every project, program and pipeline. It is this focus that enables us to consistently meet or exceed these critical research goals.

During the pilot phase of the project, MMS will provide flexible service levels based on each contributor’s ability to transform their data to ICODA standards. The MMS Biometrics and Data Science team will provide straightforward guidance for the full range of data and data mapping services as needed.

Once the pilot is complete, MMS data scientists will use the learnings to develop tools to further empower contributors such as open source code and training that academic researchers can use to transform their own data. Additionally, subsequent phases of engagement may include data mapping and incorporation of actual health data.

Learn more about ICODA here:


MMS Holdings (MMS) is an innovative, data-driven CRO that supports the pharmaceutical, biotech and medical device industries with a proven science-based approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-based services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global presence on four continents, MMS maintains a 97% customer satisfaction rate, and the company has been recognized as a leading CRO in Global Health & Pharma’s international awards programs for the past three consecutive years.

For more information visit or follow MMS on LinkedIn.


Health Data Research UK (HDR UK) is the national institute for health data science. Our mission is to unite UK health data to enable discoveries that improve people’s lives.

Health Data Research UK is a registered charity (# 1194431) funded by UK Research and Innovation, the Department of Health and Welfare in England and equivalents in Northern Ireland, Wales and Scotland, as well than by leading medical research charities. HDR UK was established in 2018 to support large-scale health data research to advance our understanding of disease and enable new discoveries that will ultimately improve health and care. We have established national research programs that use large-scale data, and we are building an infrastructure to enable responsible access and analysis of that data. Our work revolves around three themes:

  • Unify Health Data – which includes the UK Health Data Research Alliance and the Health Data Research Innovation Gateway.

  • Improve Health Data – which includes tools, methods, health data research centers and the BHF Data Science Center.

  • Using Health Data – which includes research findings and skills development in four national priority areas: understanding the causes of disease, clinical trials, public health and better care.

We implement this strategy through our inclusive and team-oriented One Institute ethics – bringing together the NHS, universities, research institutes and charities – grounded in our values.

Sean N. Ayres